Medical Devices

Asia Pacific Insulin Pens Market to 2027 - Regional Analysis and Forecasts by Product Type (Disposable and Reusable); Application (Diabetes Type-1 and Diabetes Type-2); Distribution Channel (Hospital Pharmacies, Retail Pharmacies and e-Commerce) and Geography

  • THE3262344
  • 120 Pages
  • August 2019
  • Medical Devices
Download Sample    Get Discount   
 
The Asia Pacific insulin pen market is expected to reach US$ 1,703.7 Mn in 2027 from US$ 743.4 Mn in 2018. The market is estimated to grow with a CAGR of 9.8% from 2019-2027.

The growth of the insulin pen market is primarily attributed to the growing geriatric population, increasing rate of obesity and rising incidence of diabetes. However, availability of alternatives for drug delivery and limitations associated with insulin pens are likely to pose a negative impact on the market growth. On the other hand, development of cost efficient pen needles is likely to have a positive impact on the growth of the Asia Pacific insulin pen market in the coming years.

Diabetes is a life-threatening chronic disease with no specialized cure. It is mainly caused by the body’s inability to produce or effectively utilize the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. There are two types of diabetes namely diabetes type-I also known as diabetes insipid us and diabetes type-II also termed as diabetes mellitus. Incidences and prevalence of diabetes is steadily increasing across the globe. Type 2 diabetes is the most prevalent form of diabetes and has increased alongside cultural and societal changes. In high-income countries up to 91% of adults with the disease have type 2 diabetes.

According to the International Diabetes Federation estimated that there were 382 million people with diabetes in 2013, a number exceeding its earlier predictions. Here, more than 60% of the people with diabetes live in Asia, with almost one-half in China and India combined. The Western Pacific is the world’s most populous region, has more than 138.2 million people with diabetes, and the number may rise to 201.8 million by 2035.

TABLE 1. PREVALENCE OF DIABETES WORLDWIDE, 2017

Country People with Diabetes

China 114,394.82

Japan 7,234.23

India 72,946.39

Source: International Diabetes Federation

Diabetes of all types can lead to various complications in many parts of the body and can increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss and nerve damage are the major complications associated with this disease.

Patients suffering from diabetes require frequent monitoring and external administration of insulin that is given through insulin pens and other medical devices. The rising prevalence of diabetes across the globe is expected to drive the growth of the insulin pens market worldwide during the forecast period.

In 2018, the disposable segment held a largest market share of 62.6% of the insulin pen market, by product. The disposable is expected to dominate its market share in 2027 owing to the rise in the prevalence of the diabetes and presence of the several market players that offers technically advanced products. The disposable segment is also anticipated to witness the fastest growth rate of 10% during the forecast period, 2019 to 2027.

Retail pharmacies segment a largest market share of 39.8% of the insulin pen market, by distribution channel in 2018. This segment is also expected to dominate the market in 2027 owing Chemists and retail pharmacies are considered to be the most preferred channel for patients using diabetes insulin pens. Retail pharmacies are among the most go-to places opted by the patients resulting in the high share and growth of the segment in the insulin pens market over the coming years. E-Commerce segment is also expected to grow at the fastest growth rate of 10.4% during the forecast period, 2019 to 2027.

Some of the major primary and secondary sources for insulin pen included in the report are, Owen Mumford, LTD., Novo Nordisk a/s, Companion Medical , Berlin-Chemie AG, Pendiq GmbH, Emperra GmbH E-Health Technologies, Eli lilly and company, Ypsomed Ag, SANOFI, Biocon, and others.

TABLE OF CONTENTS

Part 1.Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

Part 2.North America Diabetes Care Devices Market – Key Takeaways

Part 3.North America Diabetes Care Devices Market – Market Landscape

3.1 overview

3.2 market segmentation

3.2.1 North America Diabetes Care Devices Market – By Product

3.2.2 North America Diabetes Care Devices Market – By End USer

3.2.3 North America Diabetes Care Devices Market – By Country

3.3 PEST Analysis

Part 4.North America Diabetes Care Devices Market - Key Market Dynamics

4.1 Key Market Drivers

4.1.1 Growing Geriatric Population

4.1.2 Rapid Technological Advancements in Diabetes Care Devices

4.2 Key Market Restraints

4.2.1 High Cost of Diabetes Care Devices

4.2.2 Risks Associated with the Insulin Delivery Devices

4.3 Key Market Opportunities

4.3.1 Development of Cost Efficient Pen Needles

4.4 future Trends

4.4.1 Growing Product Innovations

4.5 Impact analysis

Part 5.Diabetes Care Devices Market – North America Analysis

5.1 North America DIABETES CARE DEVICES market Revenue Forecasts and Analysis

5.2 Market positioning

5.3 PERFORMANCE OF KEY PLAYERS

5.3.1 Medtronic

5.3.2 F. Hoffmann-La Roche Ltd.

Part 6.North America Diabetes Care Devices Market Analysis – By Product

6.1 overview

6.2 North America diabetes care devices Market BY Product, 2018 & 2027 (%)

6.3 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)

6.3.1 North America Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

6.3.2 North America Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

6.4 Glucose Monitoring Devices Market

6.4.1 Overview

6.4.2 North America Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)

6.4.3 Glucometers Market

6.4.3.1 Overview

6.4.3.2 North America Glucometers Market Revenue and Forecast to 2027 (US$ Mn)

6.4.4 Lancets Market

6.4.4.1 Overview

6.4.4.2 North America Lancets Market Revenue and Forecast to 2027 (US$ Mn)

6.4.5 Testing Strips Market

6.4.5.1 Overview

6.4.5.2 North America Testing Strips Market Revenue and Forecast to 2027 (US$ Mn)

6.4.6 Other Glucose Monitoring Devices Market

6.4.6.1 Overview

6.4.6.2 North America Other Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)

6.5 Insulin Delivery Devices Market

6.5.1 Overview

6.5.2 North America Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)

6.5.3 Insulin Pens Market

6.5.3.1 Overview

6.5.3.2 North America Insulin Pens Market Revenue and Forecast to 2027 (US$ Mn)

6.5.4 Insulin Syringes Market

6.5.4.1 Overview

6.5.4.2 North America Insulin Syringes Market Revenue and Forecast to 2027 (US$ Mn)

6.5.5 Insulin Pumps Market

6.5.5.1 Overview

6.5.5.2 North America Insulin Pumps Market Revenue and Forecast to 2027 (US$ Mn)

6.5.6 Other Insulin Delivery Devices Market

6.5.6.1 Overview

6.5.6.2 North America Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)

Part 7.North America Diabetes Care Devices Market Analysis – By End USer

7.1 Overview

7.2 NORTH AMERICA DIABETES CARE DEVICES MARKET, BY End USer, 2018 & 2027 (%)

7.3 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End USer (US$ Mn)

7.4 Homecare MArket

7.4.1 Overview

7.4.2 North America Homecare Market Revenue and Forecasts to 2027 (US$ Mn)

7.5 hospitals & Clinics Market

7.5.1 Overview

7.5.2 North America Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

Part 8.North America Diabetes Care Devices Market Revenue And Forecasts To 2027

8.1 Overview

8.2 North America DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)

8.3 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.3.1 North America Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.2 North America Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End USer (US$ Mn)

8.5 North America Diabetes care devices Market Revenue And Forecasts to 2027, By Country (%)

8.6 US DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)

8.6.1 US Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)

8.6.2 US Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.6.2.1 US Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.6.2.2 US Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.6.3 US Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)

8.7 Canada Diabetes care devices Market Revenue and Forecasts to 2027 (US$ Mn)

8.7.1 Canada Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)

8.7.2 Canada Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.7.2.1 Canada Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.7.2.2 Canada Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.7.3 Canada Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)

8.8 Mexico Diabetes care devices Market Revenue and Forecasts to 2027 (US$ Mn)

8.8.1 Mexico Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)

8.8.2 Mexico Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.8.2.1 Mexico Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.8.2.2 Mexico Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.8.3 Mexico Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)

Part 9.Diabetes Care Devices Market – Industry Landscape

9.1 Overview

9.2 Comparative Company Analysis

9.3 Growth Strategies done by the companies in the Market, (%)

9.4 Organic Developments

9.4.1 Overview

9.5 Inorganic developments

9.5.1 Overview

Part 10.Diabetes Care Devices Market–Key Company Profiles

10.1 BD

10.1.1 Key Facts

10.1.2 Business Description

10.1.3 Financial Overview

10.1.4 Product Portfolio

10.1.5 SWOT Analysis

10.1.6 Key Developments

10.2 novo nordisk a/s

10.2.1 Key Facts

10.2.2 Business Description

10.2.3 Financial Overview

10.2.4 Product Portfolio

10.2.5 SWOT Analysis

10.2.6 Key Developments

10.3 B. Braun Melsungen AG

10.3.1 Key Facts

10.3.2 Business Description

10.3.3 Financial Overview

10.3.4 Product Portfolio

10.3.5 SWOT Analysis

10.3.6 Key Developments

10.4 Medtronic

10.4.1 Key Facts

10.4.2 Business Description

10.4.3 Financial Information

10.4.4 Product Portfolio

10.4.5 SWOT Analysis

10.4.6 Key Developments

10.5 Tandem Diabetes Care, Inc.

10.5.1 Key Facts

10.5.2 Business Description

10.5.3 Financial Information

10.5.4 Product Portfolio

10.5.5 SWOT Analysis

10.5.6 Key Developments

10.6 Insulet Corporation

10.6.1 Key Facts

10.6.2 Business Description

10.6.3 Financial Information

10.6.4 Product Portfolio

10.6.5 SWOT Analysis

10.6.6 Key Developments

10.7 Eli lilly and company

10.7.1 Key Facts

10.7.2 Business Description

10.7.3 Financial Overview

10.7.4 Product Portfolio

10.7.5 SWOT Analysis

10.7.6 Key Developments

10.8 Dexcom, Inc.

10.8.1 Key Facts

10.8.2 Business Description

10.8.3 Financial Overview

10.8.4 Product Portfolio

10.8.5 SWOT Analysis

10.8.6 Key Developments

10.9 Terumo Corporation

10.9.1 Key Facts

10.9.2 Business Description

10.9.3 Financial Overview

10.9.4 Product portfolio

10.9.5 SWOT ANALYSIS

10.9.6 KEY DEVELOPMENTS

10.10 F. Hoffmann-La Roche Ltd.

10.10.1 Key Facts

10.10.2 Business Description

10.10.3 Financial Overview

10.10.4 Product Portfolio

10.10.5 SWOT Analysis

10.10.6 Key Developments

Part 11.Appendix

11.1 About The Insight Partners

11.2 Glossary of Terms

11.3 Methodology

11.3.1 Coverage

11.3.2 Secondary Research

11.3.3 Primary Research

LIST OF TABLES

Table 1. Total Number Of Persons Ofaged 60 Years Or Above By Region, 2017 & 2050

Table 2. North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 3. North America Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 4. North America Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 5. North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 6. North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 7. North America Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 8. North America Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 9. North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 10. US Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 11. US Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 12. US Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 13. US Diabetes Care Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 14. Canada Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 15. Canada Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 16. Canada Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 17. Canada Diabetes Care Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 18. Mexico Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 19. Mexico Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 20. Mexico Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 21. Mexico Diabetes Care Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 22. Organic Developments Done By Companies

Table 23. Inorganic Developments Done By Companies

Table 24. Glossary Of Terms, Diabetes Care Devices Market

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370